Volume 29, Issue 11
Research Article

A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea‐Predominant Irritable Bowel Syndrome

Chunqiu Chen

Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072 China

Dr. Chunqiu Chen and Dr. Chunhua Tao are equal contribution as co‐first author.Search for more papers by this author
Chunhua Tao

Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072 China

Dr. Chunqiu Chen and Dr. Chunhua Tao are equal contribution as co‐first author.Search for more papers by this author
Zhongchen Liu

Corresponding Author

Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072 China

Correspondence to: Zhongchen Liu, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.

E‐mail: 13860184888@163.com

Search for more papers by this author
Meiling Lu

Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072 China

Search for more papers by this author
Qiuhui Pan

Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072 China

Search for more papers by this author
Lijun Zheng

Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072 China

Search for more papers by this author
Qing Li

Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072 China

Search for more papers by this author
Zhenshun Song

Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072 China

Search for more papers by this author
Jakub Fichna

Department of Biochemistry, Medical University of Lodz, Lodz, 92‐215 Poland

Search for more papers by this author
First published: 24 September 2015
Citations: 46

Abstract

We aimed to evaluate clinical symptoms in diarrhea predominant irritable bowel syndrome (IBS‐D) receiving berberine hydrochloride in a randomized double‐blind placebo‐controlled clinical trial. Overall, 196 patients with IBS‐D were recruited for this study; consequently, 132 patients randomized to receive daily 400 mg of berberine hydrochloride, delivered twice daily or placebo for 8 weeks followed by a 4‐week washout period. After a 2‐week run‐in period, diarrhea, abdominal pain, urgent need for defecation frequency and any adverse events were recorded daily. Prior to administration of the medication and after completing the treatment, assessment of IBS symptom scores, depression and anxiety scale scores and the IBS scale for quality of life (QOL) was carried out. The effects of berberine hydrochloride on IBS‐D, defined by a reduction of diarrhea frequency (P = 0.032), abdominal pain frequency (P < 0.01) and urgent need for defecation frequency (P < 0.01), were significantly more pronounced in the berberine group than the placebo group in the 8 weeks of treatment. A trend of improvement (P < 0.05) was observed with berberine hydrochloride for IBS symptom score, depression score and anxiety score and the IBSQOL, compared with placebo. At last, berberine hydrochloride was well tolerated. So we concluded that berberine hydrochloride is well tolerated and reduces IBS‐D symptoms, which effectively improved patients QOL. Copyright © 2015 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 46

  • Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A Virus Infection, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2019.109471, 121, (109471), (2020).
  • Complementary and Alternative Medicine for Functional Gastrointestinal Disorders, The American Journal of Gastroenterology, 10.14309/ajg.0000000000000539, 115, 3, (350-364), (2020).
  • Role of a berberine-based nutritional supplement in reducing diarrhea in subjects with functional gastrointestinal disorders, Minerva Gastroenterologica e Dietologica, 10.23736/S1121-421X.19.02649-7, 66, 1, (2020).
  • Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial, Trials, 10.1186/s13063-020-04275-5, 21, 1, (2020).
  • Nanocellulose hyperfine network achieves sustained release of berberine hydrochloride solubilized with β-cyclodextrin for potential anti-infection oral administration, International Journal of Biological Macromolecules, 10.1016/j.ijbiomac.2020.03.030, 153, (633-640), (2020).
  • The antibacterial activity of Berberis heteropoda Schrenk and its effect on irritable bowel syndrome in rats, Chinese Journal of Natural Medicines, 10.1016/S1875-5364(20)30042-X, 18, 5, (356-368), (2020).
  • Berberine pharmacology and the gut microbiota: A hidden therapeutic link, Pharmacological Research, 10.1016/j.phrs.2020.104722, 155, (104722), (2020).
  • Alginate-based composite microspheres coated by berberine simultaneously improve hemostatic and antibacterial efficacy, Colloids and Surfaces B: Biointerfaces, 10.1016/j.colsurfb.2020.111168, (111168), (2020).
  • Syntheses and Structure–Activity Relationships in Growth Inhibition Activity against Human Cancer Cell Lines of 12 Substituted Berberine Derivatives, Molecules, 10.3390/molecules25081871, 25, 8, (1871), (2020).
  • Therapeutic Potential of Alkaloids as Anti-Bacterial Agents: Drugs of Future, Current Bioactive Compounds, 10.2174/1573407213666170221153319, 15, 1, (31-40), (2019).
  • Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential, Current Neuropharmacology, 10.2174/1570159X16666180419141613, 17, 6, (563-579), (2019).
  • Therapeutic potential and recent delivery systems of berberine: A wonder molecule, Journal of Functional Foods, 10.1016/j.jff.2019.103517, 61, (103517), (2019).
  • Berberine and barberry (): A clinical review, Phytotherapy Research, 10.1002/ptr.6252, 33, 3, (504-523), (2019).
  • Berberine enhances survival and axonal regeneration of motoneurons following spinal root avulsion and re-implantation in rats, Free Radical Biology and Medicine, 10.1016/j.freeradbiomed.2019.08.029, (2019).
  • Plant-Derived Products as Antibacterial and Antifungal Agents in Human Health Care, Current Medicinal Chemistry, 10.2174/0929867325666180831144344, 26, 29, (5501-5541), (2019).
  • Berberine protects against ischemia-reperfusion injury: a review of evidence from animal models and clinical studies, Pharmacological Research, 10.1016/j.phrs.2019.104385, (104385), (2019).
  • Chemical Diversity and Prediction of Potential Cultivation Areas of Cistanche Herbs, Scientific Reports, 10.1038/s41598-019-56379-x, 9, 1, (2019).
  • Nanoemulsion Improves Hypoglycemic Efficacy of Berberine by Overcoming its Gastrointestinal Challenge, Colloids and Surfaces B: Biointerfaces, 10.1016/j.colsurfb.2019.06.006, (2019).
  • Antidiarrheal Drugs, Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.65619-2, (2019).
  • Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2018.11.095, 109, (2252-2261), (2019).
  • How can we develop better antispasmodics for irritable bowel syndrome?, Expert Opinion on Drug Discovery, 10.1080/17460441.2019.1593369, (1-14), (2019).
  • Berberis Plants—Drifting from Farm to Food Applications, Phytotherapy, and Phytopharmacology, Foods, 10.3390/foods8100522, 8, 10, (522), (2019).
  • Berberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation, Drug Metabolism and Disposition, 10.1124/dmd.118.083691, 47, 2, (86-93), (2018).
  • Authentication of Dendrobium Species Using Near-Infrared and Ultraviolet–Visible Spectroscopy with Chemometrics and Data Fusion , Analytical Letters, 10.1080/00032719.2018.1451874, 51, 17, (2790-2819), (2018).
  • Berberine inhibits glucose oxidation and insulin secretion in rat islets, Endocrine Journal, 10.1507/endocrj.EJ17-0543, 65, 4, (469-477), (2018).
  • Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production, Phytomedicine, 10.1016/j.phymed.2018.04.051, (2018).
  • Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate trihydrate, C35H33NO12, Zeitschrift für Kristallographie - New Crystal Structures, 10.1515/ncrs-2018-0061, 233, 5, (865-867), (2018).
  • Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride — 4-hydroxy-3-methoxybenzoic acid — water (2/1/5), C48H54N2Cl2O17, Zeitschrift für Kristallographie - New Crystal Structures, 10.1515/ncrs-2017-0293, 233, 2, (291-293), (2018).
  • The antiviral alkaloid berberine ameliorates neuropathic pain in rats with peripheral nerve injury, Acta Neurologica Belgica, 10.1007/s13760-018-1006-9, (2018).
  • Effect of berberine on lipopolysaccharide-induced monocyte chemotactic protein-1 and interleukin-8 expression in a human retinal pigment epithelial cell line, International Ophthalmology, 10.1007/s10792-017-0697-x, 38, 5, (2053-2060), (2017).
  • Cardiotoxicity evaluation of nine alkaloids from Rhizoma Coptis , Human & Experimental Toxicology, 10.1177/0960327117695633, 37, 2, (185-195), (2017).
  • Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2017.08.001, 94, (1010-1019), (2017).
  • Recent Trends in Pharmacological Activity of Alkaloids in Animal Colitis: Potential Use for Inflammatory Bowel Disease, Evidence-Based Complementary and Alternative Medicine, 10.1155/2017/8528210, 2017, (1-24), (2017).
  • Detection of chemical constituents in Gegenqinlian decoction by ultra-high performance liquid chromatography coupled with Fourier transform ion cyclotron resonance mass spectrometry, Anal. Methods, 10.1039/C7AY02082A, 9, 40, (5890-5902), (2017).
  • Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats, Evidence-Based Complementary and Alternative Medicine, 10.1155/2017/7350251, 2017, (1-10), (2017).
  • Antidiarrheal Drug Therapy, Current Gastroenterology Reports, 10.1007/s11894-017-0557-x, 19, 5, (2017).
  • A survey of herbal weeds that are used to treat gastrointestinal disorders from southern Thailand: Krabi and Songkhla provinces, Journal of Ethnopharmacology, 10.1016/j.jep.2017.06.039, 209, (318-327), (2017).
  • A survey of herbal weeds that are used to treat gastrointestinal disorders from southern Thailand: Krabi and Songkhla provinces, Journal of Ethnopharmacology, 10.1016/j.jep.2016.11.033, 196, (84-93), (2017).
  • Nanoemulsion-based delivery system for enhanced oral bioavailability and Caco-2 cell monolayers permeability of berberine hydrochloride, Drug Delivery, 10.1080/10717544.2017.1410257, 24, 1, (1868-1873), (2017).
  • Effectiveness of Anise Oil for Treatment of Mild to Moderate Depression in Patients With Irritable Bowel Syndrome, Journal of Evidence-Based Complementary & Alternative Medicine, 10.1177/2156587216628374, 22, 1, (41-46), (2016).
  • Synergy of 2-deoxy-d-glucose combined with berberine in inducing the lysosome/autophagy and transglutaminase activation-facilitated apoptosis, Apoptosis, 10.1007/s10495-016-1315-5, 22, 2, (229-238), (2016).
  • Research progress on berberine with a special focus on its oral bioavailability, Fitoterapia, 10.1016/j.fitote.2016.02.001, 109, (274-282), (2016).
  • Berberine and inflammatory bowel disease: A concise review, Pharmacological Research, 10.1016/j.phrs.2016.09.041, 113, (592-599), (2016).
  • Herbs for Emerging Viral Infectious Diseases, Alternative and Complementary Therapies, 10.1089/act.2016.29062.eya, 22, 4, (164-174), (2016).
  • Pre-clinical toxicity of a combination of berberine and 5-aminosalicylic acid in mice, Food and Chemical Toxicology, 10.1016/j.fct.2016.08.031, 97, (150-158), (2016).
  • Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview, Molecules, 10.3390/molecules21040518, 21, 4, (518), (2016).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.